Usefulness of Fibrinogen/Fibrin Degradation Products Value in Differential Diagnosis Between Acute Ischemic Stroke and Acute Aortic Dissection

DOI IR Web Site Web Site PubMed 18 References
  • NIHEI Shun-ichi
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.
  • ARAI Hideaki
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.
  • UCHIDA Takayuki
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.
  • KANAZAWA Ayako
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.
  • ENDO Takeru
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.
  • OTSUJI Ken
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.
  • HARAYAMA Nobuya
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.
  • AIBARA Keiji
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.
  • KAMOCHI Masayuki
    Intensive Care Unit, University Hospital, University of Occupational and Environmental Health, Japan.

Bibliographic Information

Other Title
  • 急性虚血性脳卒中と急性大動脈解離の鑑別診断におけるフィブリノゲン/フィブリン分解産物の有用性

Search this article

Description

A post-marketing surveillance study reported fatalities following tissue plasminogen activator administration in acute aortic dissection (AAD) with the symptoms of acute ischemic stroke (AIS) patients. Therefore, it is important to discriminate AAD from AIS. The present study aimed to investigate whether fibrinogen/fibrin degradation products (FDP) value can be useful in differential diagnosis between AAD and AIS. The study group comprised 20 AAD patients (10 men and 10 women; age 63.9 ± 13.6 years) and 159 AIS patients (91 men and 68 women; age 74.2 ± 10.6 years) who were transported to our hospital from 2007 to 2012. The AAD cases were further divided into patent-type AAD and thrombosed-type AAD. FDP values were significantly higher in the AAD group than in the AIS group (18.15 [5.2 – 249.9] μg/ml vs. 2.3 [1.5 – 4.45] μg/ml ; P < 0.001). In AAD groups, FDP values were significantly higher in the patent-type AAD group (n = 9) than in the thrombosed type AAD group (n = 11) (293.2 μg/ml [63.1 – 419.6 μg/ml ] vs. 5.6 μg/ml [3.8 – 7.9 μg/ml ]. FDP values were significantly higher in patients with AAD than in those with AIS, especially those with patent-type AAD compared with AIS patients. High FDP values may be a useful marker for differential diagnosis between patent-type AAD and AIS.

Journal

  • Journal of UOEH

    Journal of UOEH 40 (2), 139-145, 2018-06-01

    The University of Occupational and Environmental Health, Japan

References(18)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top